Palvella Therapeutics (PVLA) Receivables: 2013-2024
Historic Receivables for Palvella Therapeutics (PVLA) over the last 8 years, with Sep 2024 value amounting to $1.0 million.
- Palvella Therapeutics' Receivables fell 3.73% to $1.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.5 million, marking a year-over-year decrease of 15.66%. This contributed to the annual value of $10.6 million for FY2022, which is 219.38% up from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Receivables is $1.0 million, which was down 77.81% from $4.5 million recorded in Q2 2024.
- Palvella Therapeutics' Receivables' 5-year high stood at $17.0 million during Q2 2021, with a 5-year trough of $829,000 in Q3 2022.
- Over the past 3 years, Palvella Therapeutics' median Receivables value was $1.2 million (recorded in 2022), while the average stood at $2.8 million.
- In the last 5 years, Palvella Therapeutics' Receivables surged by 477.45% in 2021 and then tumbled by 95.12% in 2022.
- Over the past 5 years, Palvella Therapeutics' Receivables (Quarterly) stood at $1.7 million in 2020, then spiked by 94.20% to $3.3 million in 2021, then skyrocketed by 219.38% to $10.6 million in 2022, then grew by 26.06% to $1.0 million in 2023, then decreased by 3.73% to $1.0 million in 2024.
- Its last three reported values are $1.0 million in Q3 2024, $4.5 million for Q2 2024, and $4.9 million during Q1 2024.